Myoplasmic free [Ca2+] during a malignant hyperthermia episode in swine
- PMID: 3340102
- DOI: 10.1002/mus.880110113
Myoplasmic free [Ca2+] during a malignant hyperthermia episode in swine
Abstract
Malignant hyperthermia (MH) is a genetic syndrome usually initiated by exposure to volatile anesthetic agents or depolarizing neuromuscular blocking agents. We have used Ca2+-selective microelectrodes to measure in vivo the intracellular ionized calcium ([Ca2+]i) in skeletal muscle fibers of MH-susceptible swines before and during hyperthermic episodes and also after dantrolene administration. The animals were anesthetized with thiopental and fentanyl and maintained with a mixture of nitrous oxide (66%) and oxygen (34%). The malignant hyperthermic episode was triggered by exposure to halothane. Determinations of [Ca2+]i during the episode show an increase from 0.44 +/- 0.01 microM +/- SEM, n = 20) to 8.44 +/- 0.68 microM (mean +/- SEM, n = 10). Administration of dantrolene (2 mg/kg) during the hyperthermic episode reduces [Ca2+]i to 0.17 + 0.01 microM (mean +/- SEM, n = 10) and reverses the clinical symptoms. These results show that the MH episode is associated with an increase in the myoplasmic free Ca2+ concentration and that the therapeutic effect of dantrolene is related to a decrease in [Ca2+]i.
Similar articles
-
Dantrolene sodium is able to reduce the resting ionic [Ca2+]i in muscle from humans with malignant hyperthermia.Muscle Nerve. 1987 Jan;10(1):77-9. doi: 10.1002/mus.880100114. Muscle Nerve. 1987. PMID: 3561441
-
Dantrolene prevents the malignant hyperthermic syndrome by reducing free intracellular calcium concentration in skeletal muscle of susceptible swine.Cell Calcium. 1987 Oct;8(5):385-96. doi: 10.1016/0143-4160(87)90013-3. Cell Calcium. 1987. PMID: 3427616
-
Effects of dantrolene on myoplasmic free [Ca2+] measured in vivo in patients susceptible to malignant hyperthermia.Anesthesiology. 1992 May;76(5):711-9. doi: 10.1097/00000542-199205000-00008. Anesthesiology. 1992. PMID: 1575338
-
Pathophysiology of malignant hyperthermia.Ann Fr Anesth Reanim. 1989;8(5):411-6. doi: 10.1016/S0750-7658(89)80007-3. Ann Fr Anesth Reanim. 1989. PMID: 2697155 Review.
-
Malignant hyperthermia: responses of skeletal muscles to general anesthetics.Mayo Clin Proc. 1983 Nov;58(11):758-63. Mayo Clin Proc. 1983. PMID: 6355673 Review.
Cited by
-
Memory and Learning Deficits Are Associated With Ca2+ Dyshomeostasis in Normal Aging.Front Aging Neurosci. 2020 Jul 16;12:224. doi: 10.3389/fnagi.2020.00224. eCollection 2020. Front Aging Neurosci. 2020. PMID: 32765253 Free PMC article.
-
Interpretation of relevance of sodium-calcium exchange in action potential of diabetic rat heart by mathematical model.Mol Cell Biochem. 2005 Jan;269(1-2):121-9. doi: 10.1007/s11010-005-3439-8. Mol Cell Biochem. 2005. PMID: 15786724
-
A novel RyR1-selective inhibitor prevents and rescues sudden death in mouse models of malignant hyperthermia and heat stroke.Nat Commun. 2021 Jul 13;12(1):4293. doi: 10.1038/s41467-021-24644-1. Nat Commun. 2021. PMID: 34257294 Free PMC article.
-
Chronic Elevation of Skeletal Muscle [Ca2+]i Impairs Glucose Uptake. An in Vivo and in Vitro Study.Front Physiol. 2022 Apr 25;13:872624. doi: 10.3389/fphys.2022.872624. eCollection 2022. Front Physiol. 2022. PMID: 35547584 Free PMC article.
-
Is malignant hyperthermia associated with hyperglycaemia?Br J Anaesth. 2019 Jan;122(1):e3-e5. doi: 10.1016/j.bja.2018.09.014. Epub 2018 Oct 23. Br J Anaesth. 2019. PMID: 30579418 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous